KBYP.F logo

Kobayashi Pharmaceutical OTCPK:KBYP.F Stock Report

Last Price

US$32.49

Market Cap

US$2.7b

7D

0%

1Y

n/a

Updated

18 Apr, 2024

Data

Company Financials +

Kobayashi Pharmaceutical Co., Ltd.

OTCPK:KBYP.F Stock Report

Market Cap: US$2.7b

KBYP.F Stock Overview

Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells consumer products in Japan and internationally.

KBYP.F fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance2/6
Financial Health6/6
Dividends4/6

Kobayashi Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Kobayashi Pharmaceutical
Historical stock prices
Current Share PriceJP¥32.49
52 Week HighJP¥44.03
52 Week LowJP¥32.49
Beta0.28
1 Month Changen/a
3 Month Changen/a
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO-13.26%

Recent News & Updates

Recent updates

Shareholder Returns

KBYP.FUS Personal ProductsUS Market
7D0%0.1%-3.7%
1Yn/a-32.7%20.2%

Return vs Industry: Insufficient data to determine how KBYP.F performed against the US Personal Products industry.

Return vs Market: Insufficient data to determine how KBYP.F performed against the US Market.

Price Volatility

Is KBYP.F's price volatile compared to industry and market?
KBYP.F volatility
KBYP.F Average Weekly Movementn/a
Personal Products Industry Average Movement8.6%
Market Average Movement6.0%
10% most volatile stocks in US Market16.6%
10% least volatile stocks in US Market3.0%

Stable Share Price: KBYP.F has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine KBYP.F's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
18863,534Kazumasa Kobayashiwww.kobayashi.co.jp

Kobayashi Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells consumer products in Japan and internationally. The company offers Ammeltz, a topical analgesic; Bluelet Decoral, a toilet bowl cleaner and freshener; Shoshugen, air freshener; Inochi no Haha, a women’s health medicine; Eyebon, an eye wash; Sarasaty lingerie soap; Naishitol, a Chinese medicine; Eaude Muge, a medicated lotion for preventing acne; BreathCare, an oral breath freshener capsule; Netsusama sheet, a cooling gel sheet for forehead; Sawaday, a toilet air freshener; and deodorizing air freshener, lens cleaner, and oral hygiene products. It also manufactures and sells pharmaceuticals, quasi-drugs, cosmetics, and health foods; and processed synthetic resin products; markets nutritional supplements and skin care products through website and over the phone; and sells skincare products, daily necessities, and health foods, as well as manufactures body warmers.

Kobayashi Pharmaceutical Co., Ltd. Fundamentals Summary

How do Kobayashi Pharmaceutical's earnings and revenue compare to its market cap?
KBYP.F fundamental statistics
Market capUS$2.69b
Earnings (TTM)US$131.68m
Revenue (TTM)US$1.12b

20.4x

P/E Ratio

2.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
KBYP.F income statement (TTM)
RevenueJP¥173.46b
Cost of RevenueJP¥77.08b
Gross ProfitJP¥96.38b
Other ExpensesJP¥76.04b
EarningsJP¥20.34b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)274.08
Gross Margin55.56%
Net Profit Margin11.73%
Debt/Equity Ratio0%

How did KBYP.F perform over the long term?

See historical performance and comparison

Dividends

1.8%

Current Dividend Yield

34%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.